Skip to main content
. Author manuscript; available in PMC: 2021 Sep 1.
Published in final edited form as: Schizophr Res. 2020 Jul 14;223:148–157. doi: 10.1016/j.schres.2020.06.033

Table 3.

Clinical correlations by group.

BD SAD SZ
BACS BGErr SGErr SErr BACS BGErr SGErr SErr BACS BGErr SGErr SErr
Current Symptoms
PANSS Positive −.10 .16 .12 .12 −.11 .07 .14 .20 −.13 .12 <.01 .11
PANSS Negative −.38* .23 .18 .25* −.24* .17 .18 .17 −.20 .13 .26* .13
MADRS Total −.13 .09 .04 .08 −.15 .18 .01 .09 .03 <.01 −.01 .01
YMRS Total .01 .02 .05 −.03 .03 −.07 −.04 .03 −.12 .03 −.13 .01
Medication
CPZ Dose −.16 .15 .12 .07 −.05 .04 .15 <.01 −.06 −.03 .05 −.06
Lithium Dose −.03 −.01 .15 .02 .01 −.09 .04 <.01 .02 .09 .03 .02
Valproic Acid Dose <.01 .03 .04 −.07 .06 −.02 .05 .05 −.05 −.01 .01 −.02
Sedative Use <.01 −.05 −.03 .12 −.13 .09 .12 .08 <.01 −.02 .06 −.03
Impulsivity
BIS −.05 <.01 −.06 −.05 −.16 .10 .02 .08 −.14 .05 −.03 .14
Total
BIS Attentional .07 −.01 −.06 −.05 −.07 .08 −.02 .02 −.09 .04 −.02 .13
BIS Motor −.02 −.03 −.10 −.05 −.06 .01 .03 .08 −.08 −.01 <.01 .08
BIS Non-planning −.14 .05 .01 −.04 −.19 .13 .02 .08 −.10 .07 −.03 .14
Suicide
History of suicide .03 −.02 −.05 −.01 .08 .03 −.06 .08 .09 −.08 .04 <.01
Suicide severity .03 −.01 −.05 .01 .06 .08 <.01 .11 .07 −.06 .02 .08
Suicide count .02 −.03 −.06 −.06 −.02 .06 −.10 .08 .14 −.10 −.04 −.08
BD SAD SZ
BGRT SGRT AS SSRT BGRT SGRT AS SSRT BGRT SGRT AS SSRT
Current Symptoms
PANSS Positive .03 <.01 −.04 .10 −.15 −.02 −.18 .16 .06 −.06 −.12 −.02
PANSS Negative .19 −.03 −.25* .22 .14 .06 −.12 .20 .28* .08 −.28* .14
MADRS Total .01 −.09 −.10 −.01 .05 −.07 −.11 −.02 .07 −.05 −.12 −.09
YMRS Total .04 .03 −.02 −.02 −.06 −.11 −.03 −.03 −.05 −.17 −.09 −.15
Medication
CPZ Dose .11 .02 −.11 .12 .13 .08 −.09 .03 .05 .10 .02 −.02
Lithium Dose .06 .10 .02 .13 −.06 −.03 .06 −.04 <.01 <.01 <.01 .05
Valproic Acid Dose −.01 .09 .10 −.01 <.01 .01 .01 .07 .03 .06 .01 .08
Sedative Use −.10 −.10 −.02 −.08 .07 −.04 −.14 .02 .03 .05 <.01 .03
Impulsivity
BIS Total −.13 −.08 .08 −.13 .04 −.05 −.08 .10 <.01 −.14 −.11 −.02
BIS Attentional −.14 −.10 .07 −.16 .02 .01 −.02 .13 .02 −.09 −.10 .04
BIS Motor −.17 −.09 .11 −.15 −.01 −.08 −.05 −.02 .07 −.08 −.15 <.01
BIS Non-planning −.04 −.02 .02 −.05 .07 −.04 −.11 .12 −.10 −.15 −.02 −.04
Suicide
History of suicide .01 −.06 −.07 <.01 .04 −.05 −.09 .01 .03 .05 <.01 .06
Suicide severity −.03 −.08 −.04 .01 −.01 −.12 −.09 .01 .02 .06 .03 .04
Suicide count <.01 .01 <.01 −.05 .06 −.05 −.12 −.01 −.01 −.03 −.01 −.03

BACS = Brief Assessment of Cognition in Schizophrenia; PANSS = Positive and Negative Symptom Scale; MADRS = Montgomery-Asberg Depression Rating Scale; YMRS = Young Mania Rating Scale; CPZ = Chlorpromazine equivalent antipsychotic dose; BIS = Barratt Impulsiveness Scale; BGErr = Baseline Go errors; SGErr = SST Go errors; SErr = Stop errors; BGRT = Baseline Go reaction time; SGRT = SST Go reaction time; AS = adaptive slowing; SSRT = Stop Signal Reaction Time.

*

FDR corrected p-value.